Condition

Chronic Weight Management clinical trials and research

• 7Clinical trials
• 2New in 30 days
• 7Countries

Newest Chronic Weight Management clinical trials

All recruiting trials (7)

• ASC36 tablets in adults with obesity or overweight

  A small study will test ASC36 tablets to see if they are safe and tolerated in adults with obesity or overweight, compared to placebo.

  Recruiting Phase 1 Ascletis Pharma Inc · South Miami, Florida · NCT07893106

• Two ASC36 injections in adults with obesity or overweight

  A small early study tests two ASC36 injections and their placebos to see if they are safe and how they behave in the body for adults with obesity or overweight.

  Recruiting at 2 sites Phase 1 Ascletis Pharma Inc · San Antonio, Texas and 1 other locations · NCT07893093

• ASC35 Injection in People with Overweight or Obesity

  This study tests ASC35 injections to see if they are safe and well tolerated in adults with overweight or obesity.

  Recruiting Phase 1 Ascletis Pharma Inc · Baltimore, Maryland · NCT07842640

• Once-daily ASC30 for adults who are overweight or obese with weight-related health issues

  This study tests whether three different daily doses of ASC30 can help adults who are overweight or obese with related health problems lose weight and stay safe.

  Recruiting at 6 sites Phase 3 Ascletis Pharma Inc · Birmingham, Alabama and 121 other locations · NCT07743463

• Once-daily ASC30 to See if it helps adults with obesity or overweight and Type 2 diabetes

  This study tests three daily doses of ASC30 against placebo in adults who are overweight or obese and have Type 2 diabetes to see if it helps with weight loss and safety over time.

  Recruiting at 6 sites Phase 3 Ascletis Pharma Inc · Birmingham, Alabama and 134 other locations · NCT07743450

• Aleniglipron for adults with overweight/obesity and type 2 diabetes

  A long-term test to see if aleniglipron helps weight loss and blood sugar control in adults who are overweight or obese and have type 2 diabetes.

  Recruiting at 57 sites Phase 3 Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics · Birmingham, Alabama and 73 other locations · NCT07654374

• Aleniglipron for weight management in obesity or overweight with a related condition

  This study tests whether aleniglipron, taken daily, helps people with obesity or overweight plus a weight-related condition lose weight when added to a reduced-calorie diet and more activity, compared with a placebo.

  Recruiting at 13 sites Phase 3 Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics · Birmingham, Alabama and 70 other locations · NCT07654361

Related topics

Quick answers

How many Chronic Weight Management clinical trials are recruiting right now?

7, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in United States (7 trials), Czechia (2 trials), Germany (2 trials), Greece (2 trials), Poland (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 4, Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →